Dr. Lynda G. Kabbash, MD

Dr. Kabbash practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Kabbash's NPI, 1124006515, was assigned on January 5, 2006. Dr. Kabbash graduated from McGill University Faculty of Medicine in 1977. Dr. Kabbash holds Massachusetts license 71639.

Dr. Kabbash's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Kabbash's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Kabbash is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Allergy & Asthma Center of Massachusetts. Dmand AI also links Dr. Kabbash to 4 more medical groups, 1 community health center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kabbash practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Kabbash's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dmand AI has Dr. Kabbash's licenses on file in 3 states: Massachusetts, New York and California.

Dmand AI lists asthma, chronic nasal allergies and hives among the conditions Dr. Kabbash treats.

CMS data shows 125 Medicare services from Dr. Kabbash across 3 procedure codes in 2024, all of them office visits, for 124 Medicare patients. Medicare paid $11,289 for them.

CMS counts 124 Medicare patients who saw Dr. Kabbash in 2024. The largest group is 65 to 74, with 63 patients. 69% of them have high cholesterol, and 61% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kabbash's median patient age at 46, with 73% women.

In 2024, Dr. Kabbash wrote 113 Medicare Part D claims for 46 patients. 57% of them were for generic drugs. CMS names the drug for 73 of them, across 5 drugs with 11 or more claims each, at $44,277 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

Dr. Kabbash accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kabbash as offering telehealth.

Dmand AI links 8 papers to Dr. Kabbash in 2024. The most frequent topics are Antigens, Differentiation, Neutrophils and Antibodies, Monoclonal. Dr. Kabbash has published most often in J Allergy Clin Immunol Pract. Dr. Kabbash's most frequent co-authors are Stuart Lee Abramson, MD, Adam Asch, MD and Priya J. Bansal, MD.

CMS Open Payments shows 6 general payments to Dr. Kabbash from 3 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $95.

Dmand AI lists 2 awards for Dr. Kabbash, most recently CMS Stage 1 EHR in 2013.

Dr. Kabbash graduated from McGill University Faculty of Medicine in 1977. Dr. Kabbash is a member of AAAAI.

Dr. Kabbash is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.